Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RARB | P10826 | 3/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.34 |
| ▸ | PLA2G4B | P0C869 | 3/20 | 0.33 |
| ▸ | APP | P05067 | 1/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | NR5A1 | Q13285 | 1/20 | 0.33 |
| ▸ | MMP2 | P08253 | 1/20 | 0.33 |
| ▸ | ESR1 | P03372 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9910768 | 0.96 | APP (0.39) | RARBPLA2G4BAPPTP53TSHR | |
| SCHEMBL9909996 | 0.85 | RARB (0.32) | RARBCYP1A2CYP3A4CYP2D6PLA2G4B | |
| SCHEMBL14335749 | 0.85 | RARB (0.37) | RARBCYP1A2CYP3A4CYP2D6PLA2G4B | |
| SCHEMBL9910001 | 0.84 | PTGES (0.43) | RARBPLA2G4BAPPTP53TSHR | |
| SCHEMBL22784130 | 0.82 | PTGES (0.43) | RARBPLA2G4BAPPTP53TSHR | |
| SCHEMBL22770695 | 0.80 | RARB (0.35) | RARBCYP1A2CYP3A4CYP2D6TP53 | |
| SCHEMBL22770709 | 0.80 | S1PR1 (0.33) | RARB | |
| SCHEMBL31684373 | 0.80 | S1PR1 (0.33) | RARB | |
| SCHEMBL9910011 | 0.79 | RARB (0.35) | RARBCYP1A2CYP3A4CYP2D6PLA2G4B | |
| SCHEMBL12160895 | 0.79 | RARB (0.35) | RARBCYP1A2CYP3A4CYP2D6PLA2G4B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8586764-B2 | Organic dyes and preparation method thereof and dye-sensitized solar cells | China National Academy of Nanotechnology and Engineering (CN) | 2013-11-19 | — | — | US | disclosed |
| US-20120138133-A1 | ORGANIC DYES AND PREPARATION METHOD THEREOF AND DYE-SENSITIZED SOLAR CELLS | China National Academy of Nanotechnology and Engineering (CN) | 2012-06-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120138133-A1 | ORGANIC DYES AND PREPARATION METHOD THEREOF AND DYE-SENSITIZED SOLAR CELLS | UROD, TYR, DDT | RARB 1160/4885CYP1A2 1178/4885CYP3A4 313/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.